Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michi Morita
Prognostic Implications of HER2 Heterogeneity in Gastric Cancer
Oncotarget
Oncology
Related publications
Metabolic Landscape of Advanced Gastric Cancer According to HER2 and Its Prognostic Implications
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Loss of HER2 Positivity After Anti-Her2 Chemotherapy in HER2-positive Gastric Cancer Patients: Results of the GASTric Cancer HER2 Reassessment Study 3 (GASTHER3)
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Positive Prognostic Value of HER2-HER3 Co-Expression and P-mTOR in Gastric Cancer Patients
BMC Cancer
Cancer Research
Oncology
Genetics
Prevalence and Prognostic Implications of Psychological Distress in Patients With Gastric Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Clinical Significance of Intratumoral HER2 Heterogeneity on Trastuzumab Efficacy Using Endoscopic Biopsy Specimens in Patients With Advanced HER2 Positive Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Perspectives of HER2-targeting in Gastric and Esophageal Cancer
Expert Opinion on Investigational Drugs
Medicine
Pharmacology
HER2 Testing in Gastric Cancer: A Practical Approach
Modern Pathology
Forensic Medicine
Pathology
Prognostic Significance of FKBP14 in Gastric Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Molecular Heterogeneity and Prognostic Implications of Synchronous Advanced Colorectal Neoplasia
British Journal of Cancer
Cancer Research
Oncology
